Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Bauer

Showing results (281-290 of 408) with videos related to

Pageof 41
Sort By:
Frontiers in Genetics|May 27, 2021
GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular TumorsPhilipp Jansen, Hansgeorg Müller, Georg C Lodde, et al.
Journal of Cancer Research and Clinical Oncology|June 10, 2022
Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcomaMonika Scheer, Erika Hallmen, Christian Vokuhl, et al.
Journal for Immunotherapy of Cancer|January 18, 2019
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trialUlrich Keilholz, Janice M Mehnert, Sebastian Bauer, et al.
Epilepsy & Behavior : E&B|January 25, 2021
Postoperative outcomes and surgical ratio at a newly established epilepsy center: The first 100 proceduresCatrin Mann, Nadine Conradi, Thomas M Freiman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialHeikki Joensuu, Eva Wardelmann, Mikael Eriksson, et al.
British Journal of Cancer|June 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trialHeikki Joensuu, Annette Reichardt, Mikael Eriksson, et al.
Future Oncology (London, England)|September 4, 2024
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with <i>KIT</i> exon 11 + 17/18 mutationsSuzanne George, Jean-Yves Blay, Ping Chi, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2022
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent gliomaLazaros Lazaridis, Teresa Schmidt, Christoph Oster, et al.
Cancers|November 26, 2022
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic SettingJohanna Falkenhorst, Susanne Grunewald, Dawid Krzeciesa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Pageof 41

Showing results (281-290 of 408) with videos related to

Sort By:
Pageof 41
Frontiers in Genetics|May 27, 2021
GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular TumorsPhilipp Jansen, Hansgeorg Müller, Georg C Lodde, et al.
Journal of Cancer Research and Clinical Oncology|June 10, 2022
Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcomaMonika Scheer, Erika Hallmen, Christian Vokuhl, et al.
Journal for Immunotherapy of Cancer|January 18, 2019
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trialUlrich Keilholz, Janice M Mehnert, Sebastian Bauer, et al.
Epilepsy & Behavior : E&B|January 25, 2021
Postoperative outcomes and surgical ratio at a newly established epilepsy center: The first 100 proceduresCatrin Mann, Nadine Conradi, Thomas M Freiman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialHeikki Joensuu, Eva Wardelmann, Mikael Eriksson, et al.
British Journal of Cancer|June 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trialHeikki Joensuu, Annette Reichardt, Mikael Eriksson, et al.
Future Oncology (London, England)|September 4, 2024
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with <i>KIT</i> exon 11 + 17/18 mutationsSuzanne George, Jean-Yves Blay, Ping Chi, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2022
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent gliomaLazaros Lazaridis, Teresa Schmidt, Christoph Oster, et al.
Cancers|November 26, 2022
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic SettingJohanna Falkenhorst, Susanne Grunewald, Dawid Krzeciesa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Pageof 41